Showing 26–50 of 136 · North America
FY2025 revenue C$15.91bn (+8.4%); pre-tax margin 14.1%; net income C$1.66bn.
Net debt C$3.45bn; long-term debt and leases C$4.33bn.
FY2026 revenue $63.33bn (+12.0%); operating margin 24.3%; net income $13.27bn.
Cash $15.92bn; debt $29.53bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $4.81bn (+21.7%); operating margin -6.1%; net loss $162.5m.
Cash $5.23bn; debt $745.5m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $113.54bn (+19.0%); operating margin 7.2%; net income $5.94bn.
Cash $11.53bn; debt $31.50bn.
FY2025 revenue $4.66bn (+15.6%); operating margin 19.6%; net income $836.3m.
Cash $2.00bn; debt $1.24bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $6.07bn (+11.5%); operating margin 20.8%; net income $1.06bn.
Cash $3.00bn; debt $600.0m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Experian (EXPN.L) group FY2026 revenue $8.45bn (+12.3%); operating margin 24.2%.
Benchmark EBIT $2.40bn (+15%); net debt 1.7x Benchmark EBITDA.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.
Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).
FY2025 revenue $6.80bn (+14.2%); operating margin 30.7%; net income $1.85bn.
Cash $3.92bn; debt $996.3m.
Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.
Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).
FY2025 revenue $20.62bn (+4.8%); operating margin 13.4%; net income $2.08bn.
Cash $4.51bn; debt $10.00bn.
Parent Alphabet (GOOGL) group FY2025 revenue $402.84bn (+15.1%); operating margin 32.0%; net income $132.17bn.
Figures cover the whole listed group, not this business alone.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $311.1m (+1.5%); operating margin -51.7%; net loss $178.0m.
Cash $95.7m; debt $153.3m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $176.0m (+40.0%); operating margin -36.4%; net loss $116.8m.
No debt; $280.2m cash.
FY2025 revenue $34.30bn (+13.8%); operating margin -1.3%; net income $57.0m.
GAAP operating loss of $437m; net earnings $57m.